
Deepa Belur
Examiner (ID: 2176, Phone: (571)270-3722 , Office: P/2472 )
| Most Active Art Unit | 2472 |
| Art Unit(s) | 2472 |
| Total Applications | 650 |
| Issued Applications | 513 |
| Pending Applications | 62 |
| Abandoned Applications | 96 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19032620
[patent_doc_number] => 20240082435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Solid phase synthesis of glutamate-urea-lysine derived (GUL derived) prostate-specific membrane antigen (PSMA) targeting conjugates and their use as precursors for therapeutic and/or diagnostic agents
[patent_app_type] => utility
[patent_app_number] => 18/547286
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547286 | Solid phase synthesis of glutamate-urea-lysine derived (GUL derived) prostate-specific membrane antigen (PSMA) targeting conjugates and their use as precursors for therapeutic and/or diagnostic agents | Feb 24, 2022 | Pending |
Array
(
[id] => 19439988
[patent_doc_number] => 12090215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Method and device for direct production of radio-isotope based cancer treatment pharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 17/649930
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14722
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17649930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/649930 | Method and device for direct production of radio-isotope based cancer treatment pharmaceuticals | Feb 3, 2022 | Issued |
Array
(
[id] => 18075979
[patent_doc_number] => 20220401591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => SYSTEM AND METHOD FOR QUANTITATIVE MAPPING OF MITOCHONDRIAL COMPLEX 1
[patent_app_type] => utility
[patent_app_number] => 17/592684
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592684 | SYSTEM AND METHOD FOR QUANTITATIVE MAPPING OF MITOCHONDRIAL COMPLEX 1 | Feb 3, 2022 | Abandoned |
Array
(
[id] => 17577091
[patent_doc_number] => 20220133946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => ELECTROSPUN BIOCOMPATIBLE FIBER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/574838
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574838 | ELECTROSPUN BIOCOMPATIBLE FIBER COMPOSITIONS | Jan 12, 2022 | Abandoned |
Array
(
[id] => 19002084
[patent_doc_number] => 20240066155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => DUAL MODE RADIOTRACER AND -THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 18/260272
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260272
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260272 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | Jan 3, 2022 | Pending |
Array
(
[id] => 17532443
[patent_doc_number] => 20220111052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ELUENT SOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/557755
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557755 | ELUENT SOLUTION | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17655488
[patent_doc_number] => 20220175953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/550542
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/550542 | BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY | Dec 13, 2021 | Pending |
Array
(
[id] => 17627206
[patent_doc_number] => 20220162221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 17/534711
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534711
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534711 | Imaging Agents | Nov 23, 2021 | Abandoned |
Array
(
[id] => 18947083
[patent_doc_number] => 11890356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => HDAC6 inhibitors and imaging agents
[patent_app_type] => utility
[patent_app_number] => 17/455170
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 22364
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17455170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/455170 | HDAC6 inhibitors and imaging agents | Nov 15, 2021 | Issued |
Array
(
[id] => 17593658
[patent_doc_number] => 20220143231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/522144
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522144
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/522144 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | Nov 8, 2021 | Abandoned |
Array
(
[id] => 17426956
[patent_doc_number] => 20220054664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/517039
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517039 | PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF | Nov 1, 2021 | Pending |
Array
(
[id] => 18816083
[patent_doc_number] => 20230390422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => OLIGONUCLEOTIDE-BASED THERAPEUTICS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/251217
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251217
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251217 | OLIGONUCLEOTIDE-BASED THERAPEUTICS AND USES THEREOF | Oct 28, 2021 | Abandoned |
Array
(
[id] => 17355477
[patent_doc_number] => 20220016273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => COMPOSITION FOR DIAGNOSIS OF FUNGAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/491593
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491593 | COMPOSITION FOR DIAGNOSIS OF FUNGAL INFECTION | Sep 30, 2021 | Pending |
Array
(
[id] => 18877610
[patent_doc_number] => 20240000979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHODS AND COMPOSITIONS FOR SYNERGISTIC UPTAKE AND RETENTION OF SMALL MOLECULE LIGANDS
[patent_app_type] => utility
[patent_app_number] => 18/247427
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247427
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247427 | METHODS AND COMPOSITIONS FOR SYNERGISTIC UPTAKE AND RETENTION OF SMALL MOLECULE LIGANDS | Sep 27, 2021 | Pending |
Array
(
[id] => 18769501
[patent_doc_number] => 20230364271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING UPTAKE, INTERNALIZATION, AND/OR RETENTION OF SMALL MOLECULE LIGANDS
[patent_app_type] => utility
[patent_app_number] => 18/029596
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029596 | METHODS AND COMPOSITIONS FOR INCREASING UPTAKE, INTERNALIZATION, AND/OR RETENTION OF SMALL MOLECULE LIGANDS | Sep 27, 2021 | Pending |
Array
(
[id] => 17355478
[patent_doc_number] => 20220016274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => RADIOPHARMACEUTICAL AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/486875
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17486875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/486875 | RADIOPHARMACEUTICAL AND METHODS | Sep 26, 2021 | Abandoned |
Array
(
[id] => 18755298
[patent_doc_number] => 20230358726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => NON-INVASIVE FUNCTIONAL COMPANION ASSAYS FOR ONCOGENE TARGETED THERAPY FOR BRAIN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/027311
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027311 | NON-INVASIVE FUNCTIONAL COMPANION ASSAYS FOR ONCOGENE TARGETED THERAPY FOR BRAIN CANCER | Sep 20, 2021 | Pending |
Array
(
[id] => 18193659
[patent_doc_number] => 20230047178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => HETEROARYL COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/477411
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477411 | HETEROARYL COMPOUNDS AND USES THEREOF | Sep 15, 2021 | Abandoned |
Array
(
[id] => 18413095
[patent_doc_number] => 11667628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Compounds for imaging tau proteins that accumulate in brain
[patent_app_type] => utility
[patent_app_number] => 17/477479
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 35
[patent_no_of_words] => 30624
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477479 | Compounds for imaging tau proteins that accumulate in brain | Sep 15, 2021 | Issued |
Array
(
[id] => 17312966
[patent_doc_number] => 20210402014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPLEX POLYSACCHARIDE-BOUND RADIOISOTOPE CHELATES AND METHODS OF TREATING MALIGNANCIES THEREWITH
[patent_app_type] => utility
[patent_app_number] => 17/474916
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474916 | COMPLEX POLYSACCHARIDE-BOUND RADIOISOTOPE CHELATES AND METHODS OF TREATING MALIGNANCIES THEREWITH | Sep 13, 2021 | Abandoned |